Published in Vision Res on December 22, 2009
Dual suppression of hemangiogenesis and lymphangiogenesis by splice-shifting morpholinos targeting vascular endothelial growth factor receptor 2 (KDR). FASEB J (2012) 0.89
Retinoid receptors trigger neuritogenesis in retinal degenerations. FASEB J (2011) 0.86
SPARC/osteonectin is involved in metastatic process to the lung during melanoma progression. Virchows Arch (2014) 0.82
Deletion of SPARC Enhances Retinal Vaso-Obliteration in Mouse Model of Oxygen-Induced Retinopathy. HSOA J Ophthalmol Clin Res (2014) 0.75
Targeted Delivery of FLT-Morpholino Using Cyclic RGD Peptide. Transl Vis Sci Technol (2017) 0.75
Ranibizumab for neovascular age-related macular degeneration. N Engl J Med (2006) 30.63
What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst (1990) 13.41
Pegaptanib for neovascular age-related macular degeneration. N Engl J Med (2004) 12.01
The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (1992) 7.49
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med (2001) 6.73
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
Corneal avascularity is due to soluble VEGF receptor-1. Nature (2006) 4.77
Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res (2005) 4.38
Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol (2002) 4.23
Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 3.17
Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol (2006) 3.12
The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem (1996) 2.75
Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell (1997) 2.24
Role of VEGF-flt receptor system in normal and tumor angiogenesis. Adv Cancer Res (1995) 2.14
Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol (2005) 1.97
Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci (1994) 1.90
Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol (2007) 1.89
Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. Cancer Res (2001) 1.85
SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem (1998) 1.74
Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J Biol Chem (1996) 1.73
Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol (2001) 1.69
VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO J (2005) 1.63
Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. Blood (2002) 1.48
Corneal neovascularization. Pathogenesis and inhibition. Cornea (1987) 1.47
Fundus autofluorescence and progression of age-related macular degeneration. Surv Ophthalmol (2009) 1.46
SPARC: a matricellular regulator of tumorigenesis. J Cell Commun Signal (2009) 1.41
Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J Clin Invest (2006) 1.36
Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 1.34
SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells. J Cell Biochem (2004) 1.24
Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization. J Cell Physiol (2004) 1.19
Inhibition of PDGF-stimulated and matrix-mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin-dependent kinase inhibitors. J Cell Biochem (2002) 1.08
Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC). Eye (Lond) (2002) 1.05
Exacerbated corneal inflammation and neovascularization in the HO-2 null mice is ameliorated by biliverdin. Exp Eye Res (2008) 0.96
Molecular docking and analysis of interactions between vascular endothelial growth factor (VEGF) and SPARC protein. J Mol Graph Model (2007) 0.90
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature (2008) 7.10
An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med (2003) 6.61
Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol (2003) 5.22
Corneal avascularity is due to soluble VEGF receptor-1. Nature (2006) 4.77
Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N Engl J Med (2008) 4.46
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration. Nature (2011) 3.90
Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A (2006) 3.25
Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 3.17
DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88. Cell (2012) 2.81
Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med (2009) 2.39
CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature (2009) 2.39
Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A (2008) 1.70
Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity. Blood (2013) 1.56
HTRA1 variant confers similar risks to geographic atrophy and neovascular age-related macular degeneration. Cell Cycle (2007) 1.53
Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice. Proc Natl Acad Sci U S A (2011) 1.45
Genetic association of LOXL1 gene variants and exfoliation glaucoma in a Utah cohort. Cell Cycle (2008) 1.43
Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival. Int J Biol Sci (2007) 1.40
Loss of SPARC-mediated VEGFR-1 suppression after injury reveals a novel antiangiogenic activity of VEGF-A. J Clin Invest (2006) 1.36
Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth. Proc Natl Acad Sci U S A (2009) 1.36
Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci (2003) 1.34
Nanoparticles sustain expression of Flt intraceptors in the cornea and inhibit injury-induced corneal angiogenesis. Invest Ophthalmol Vis Sci (2007) 1.25
Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier. Br J Ophthalmol (2006) 1.22
Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention. Toxicology (2009) 1.21
Corneal transparency: genesis, maintenance and dysfunction. Brain Res Bull (2009) 1.18
Mediators of ocular angiogenesis. J Genet (2009) 1.17
UNC-108/RAB-2 and its effector RIC-19 are involved in dense core vesicle maturation in Caenorhabditis elegans. J Cell Biol (2009) 1.16
Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo. Invest Ophthalmol Vis Sci (2005) 1.13
Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3. Mol Ther (2011) 1.09
Corneal stroma PDGF blockade and myofibroblast development. Exp Eye Res (2008) 1.08
Anterior chamber intraocular lens, sutured posterior chamber intraocular lens, or glued intraocular lens: where do we stand? Curr Opin Ophthalmol (2012) 1.07
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1. Elife (2013) 1.06
Size effect of elemental selenium nanoparticles (Nano-Se) at supranutritional levels on selenium accumulation and glutathione S-transferase activity. J Inorg Biochem (2007) 1.04
Morpholino-mediated increase in soluble Flt-1 expression results in decreased ocular and tumor neovascularization. PLoS One (2012) 1.00
ERK1/2 activation is a therapeutic target in age-related macular degeneration. Proc Natl Acad Sci U S A (2012) 0.99
Association of HTRA1 polymorphism and bilaterality in advanced age-related macular degeneration. Vision Res (2008) 0.98
Whirlin replacement restores the formation of the USH2 protein complex in whirlin knockout photoreceptors. Invest Ophthalmol Vis Sci (2011) 0.97
Role for PPARgamma in IL-2 inhibition in T cells by Echinacea-derived undeca-2E-ene-8,10-diynoic acid isobutylamide. Int Immunopharmacol (2009) 0.94
Unique homologous siRNA blocks hypoxia-induced VEGF upregulation in human corneal cells and inhibits and regresses murine corneal neovascularization. Cornea (2007) 0.93
The capsule drug device: novel approach for drug delivery to the eye. Vision Res (2009) 0.93
Flt-1 intraceptor induces the unfolded protein response, apoptotic factors, and regression of murine injury-induced corneal neovascularization. Invest Ophthalmol Vis Sci (2006) 0.93
Targeted drug and gene delivery systems for lung cancer therapy. Clin Cancer Res (2009) 0.92
Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest (2014) 0.92
Targeted intraceptor nanoparticle therapy reduces angiogenesis and fibrosis in primate and murine macular degeneration. ACS Nano (2013) 0.91
Molecular docking and analysis of interactions between vascular endothelial growth factor (VEGF) and SPARC protein. J Mol Graph Model (2007) 0.90
Quality of vision and patient satisfaction after LASIK. Curr Opin Ophthalmol (2004) 0.90
Horizons in therapy for corneal angiogenesis. Ophthalmology (2011) 0.90
Dual suppression of hemangiogenesis and lymphangiogenesis by splice-shifting morpholinos targeting vascular endothelial growth factor receptor 2 (KDR). FASEB J (2012) 0.89
Surface-functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium. FASEB J (2009) 0.88
Nanoparticle-mediated delivery of shRNA.VEGF-a plasmids regresses corneal neovascularization. Invest Ophthalmol Vis Sci (2012) 0.88
Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention. Int J Nanomedicine (2012) 0.86
Retinoid receptors trigger neuritogenesis in retinal degenerations. FASEB J (2011) 0.86
Aquaporin-1 expression is decreased in human and mouse corneal endothelial dysfunction. Mol Vis (2004) 0.85
Flt23k nanoparticles offer additive benefit in graft survival and anti-angiogenic effects when combined with triamcinolone. Invest Ophthalmol Vis Sci (2012) 0.85
[The prevalence and its screening methods of primary open angle glaucoma in defined population-based study of rural and urban in Beijing]. Zhonghua Yan Ke Za Zhi (2004) 0.84
Mechanisms and genes involved in enhancement of HIV infectivity by tobacco smoke. Toxicology (2010) 0.84
Microstructural White Matter Abnormalities and Cognitive Dysfunction in Subcortical Ischemic Vascular Disease: an Atlas-Based Diffusion Tensor Analysis Study. J Mol Neurosci (2015) 0.84
Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization. Biochem Biophys Res Commun (2005) 0.83
Effect of glucocorticoid (triamcinolone acetonide) pretreatment in a murine penetrating keratoplasty and suture model. Cornea (2012) 0.83
HIV infection: an independent risk factor of peripheral arterial disease. J Acquir Immune Defic Syndr (2010) 0.82
Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation. J Control Release (2013) 0.82
Molecular modeling of the oxidized form of nuclear factor-kappa B suggests a mechanism for redox regulation of DNA binding and transcriptional activation. J Mol Graph Model (2007) 0.81
A -1 frameshift in the HIV-1 env gene is enhanced by arginine deficiency via a hungry codon mechanism. Mutat Res (2005) 0.81
Impact of Partial and complete rupture of anterior cruciate ligament on medial meniscus: A cadavaric study. Indian J Orthop (2012) 0.81
Progress on materials and scaffold fabrications applied to esophageal tissue engineering. Mater Sci Eng C Mater Biol Appl (2013) 0.80
[Considerations about study on mechanisms of thermal efficacies of moxibustion from activities of transient receptor potential family]. Zhen Ci Yan Jiu (2012) 0.80
The influence of traditional herbal formulas on cytokine activity. Toxicology (2009) 0.79
Gene delivery nanoparticles fabricated by supercritical fluid extraction of emulsions. Int J Pharm (2009) 0.79
Preliminary study on the mechanism of acupoint injection of bone marrow mesenchymal stem cells in improving blood flow in the rat of hind limb ischemia. J Tradit Chin Med (2011) 0.79
Inhibition of glutathione synthesis eliminates the adaptive response of ascitic hepatoma 22 cells to nedaplatin that targets thioredoxin reductase. Toxicol Appl Pharmacol (2012) 0.78
Dry eye predisposes to corneal neovascularization and lymphangiogenesis after corneal injury in a murine model. Cornea (2014) 0.78
Structure and dynamics of a predicted ferredoxin-like selenoprotein in Japanese encephalitis virus. J Mol Graph Model (2004) 0.78
Premature atherosclerosis in patients with acquired immunodeficiency syndrome. Chin Med J (Engl) (2010) 0.78
Effect of activated autologous monocytes/macrophages on wound healing in a rodent model of experimental diabetes. Diabetes Res Clin Pract (2013) 0.78
Development and Preliminary Application of a Peptide Mass Fingerprinting Technique in Proteome Research. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) (2000) 0.77
GATA-3 augmentation down-regulates Connexin43 in Helicobacter pylori associated gastric carcinogenesis. Cancer Biol Ther (2015) 0.77
Ocular drug delivery for glaucoma management. Pharmaceutics (2012) 0.77
Gene Expression Profiles at Moxibustioned Site (ST36): A Microarray Analysis. Evid Based Complement Alternat Med (2013) 0.77
Vascular endothelial growth factor receptor 1 morpholino decreases angiogenesis in a murine corneal suture model. Invest Ophthalmol Vis Sci (2012) 0.77
Sorption and ecotoxicity of pentachlorophenol polluted sediment amended with rice-straw derived biochar. Bioresour Technol (2010) 0.76
The pilot study of DXA assessment in chinese HIV-infected men with clinical lipodystrophy. J Clin Densitom (2010) 0.76
[The impact of highly active antiretroviral therapy on bone mineral density in human immunodeficiency virus infected patients]. Zhonghua Nei Ke Za Zhi (2010) 0.76
Functional studies of an HIV-1 encoded glutathione peroxidase. Biofactors (2006) 0.76